Chennai, India

Anuja Chandrasekar


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anuja Chandrasekar: Innovator in Pharmaceutical Formulations

Introduction

Anuja Chandrasekar is a prominent inventor based in Chennai, India. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable antibody formulations. With a total of 3 patents to her name, her work is paving the way for advancements in therapeutic applications.

Latest Patents

Anuja's latest patents include innovative formulations that enhance the stability of therapeutic antibodies. One of her notable inventions is a stable pharmaceutical formulation of an antibody that contains a buffer, surfactant, and sugar, while being devoid of free amino acids and salts. This formulation is designed to maintain the integrity of the antibody during storage. Another significant patent discloses a similar stable formulation that optionally includes a free amino acid, ensuring that the antibody remains stable at 50° C. for two weeks, while maintaining at least 96% of the antibody in monomeric form under these conditions.

Career Highlights

Anuja is currently employed at Dr. Reddy's Laboratories, Incorporated, where she continues to innovate in the pharmaceutical sector. Her work focuses on creating formulations that improve the efficacy and stability of therapeutic agents, which is crucial for patient treatment and care.

Collaborations

Anuja collaborates with her coworker, Murali Jayaraman, to further enhance the research and development of pharmaceutical formulations. Their combined expertise contributes to the success of their projects and the advancement of their field.

Conclusion

Anuja Chandrasekar is a dedicated inventor whose work in stable pharmaceutical formulations is making a significant impact in the industry. Her innovative patents and collaborations are essential for the future of therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…